Metabolomic profiling of Cohort Consortium identifies prodromal biomarkers for Parkinson’s disease

by | Dec 6, 2024 | Scientific presentation

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Speaker | Nadia Ashrafi, Ph.D.
Affiliation | Metabolomics Research Group | Corewell Health Research Institute | Corewell Health East William Beaumont University Hospital | Research Scientist


Metabolomic profiling of Cohort Consortium identifies prodromal biomarkers for Parkinson’s disease

Part of the
Corewell Health Metabolomics Symposium

Comprehensive metabolomic profiling of the LRRK2 Cohort Consortium (LCC) identifies prodromal biomarkers for Parkinson’s Disease


Related articles

Upcoming events

Biognosys Group at AACR

Date Apr 17 - 22, 2026Time All Day EventVenue San Diego Convention Center

The AACR (American Association for Cancer Research) Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer scienc...

More Info

Global Exposome Summit

Date Apr 27 - 29, 2026Time All Day EventVenue Sitges, Barcelona

The Global Exposome Summit brings together leading researchers, policymakers, and industry stakeholders to advance international collaboration in exposome science and its applications to human health. The event highlights the latest methodological, scientific, and infra...

More Info

Canadian Metabolomics Conference

Date Apr 30 - May 1, 2026Time All Day EventVenue York University’s Cornerstone Centre – Toronto, Canada

The 7th Annual Canadian Metabolomics Conference (CanMetCon 2026) will bring together Canadian and international experts to discuss the latest advances in metabolomics and multi‑omics research, with a focus on health and disease.

More Info